title: Novel functional magnetic resonance imaging biomarkers for assessing response to therapy in hepatocellular carcinoma.
abstract: The established and adapted image biomarkers based on size for tumor burden measurement continue to be applied to hepatocellular carcinoma (HCC) as size measurement can easily be used in clinical practice. However, in the setting of novel targeted therapies and liver directed treatments, simple tumor anatomical changes can be less informative and usually appear later than biological changes. Functional magnetic resonance imaging (MRI) has a potential to be a promising technique for assessment of HCC response to therapy. In this review, we discuss various functional MRI biomarkers that play an increasingly important role in evaluation of HCC response after treatment.
authors.affiliation: Department of Radiology, Shanghai PLA No. 85 Hospital, 1328 Hua Shan Road, Shanghai, 200052, People's Republic of China, yuanzheng0404@163.com.
authors.forename: Z
authors.initials: Z
authors.lastname: Yuan
authors.forename: W-T
authors.initials: WT
authors.lastname: Li
authors.forename: X-D
authors.initials: XD
authors.lastname: Ye
authors.forename: H-Y
authors.initials: HY
authors.lastname: Zhu
authors.forename: W-J
authors.initials: WJ
authors.lastname: Peng
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000473:pathology* / Q000628:therapy; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D008113:Liver Neoplasms / Q000473:pathology* / Q000628:therapy; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009682:Magnetic Resonance Spectroscopy; D016896:Treatment Outcome